In conclusion, CHML significantly influences the migratory capacity of HCC cells by modulating a variety of migration-related signaling pathways, including MAPK and PI3K-AKT, as well as by orchestrating metabolic reprogramming. The gene discussed is AKT1; the disease is hepatocellular carcinoma.